SCI Pharmtech Inc (4119) — Cash Flow-to-Debt Ratio
SCI Pharmtech Inc (4119) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2026, meaning its operating cash flow of NT$156.75 Million could theoretically repay 0% of its total liabilities (NT$1.62 Billion) in one year. See SCI Pharmtech Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
SCI Pharmtech Inc Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for SCI Pharmtech Inc across 23 annual periods. For the full cash flow conversion analysis, see SCI Pharmtech Inc (4119) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for SCI Pharmtech Inc (2002–2025)
Year-by-year debt coverage analysis for SCI Pharmtech Inc. Check earnings quality score of SCI Pharmtech Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | NT$220.32 Million | NT$1.49 Billion | ▼ -70.4% |
| 2024 | 0.50x | NT$860.52 Million | NT$1.72 Billion | ▲ +268.0% |
| 2023 | 0.14x | NT$215.77 Million | NT$1.59 Billion | ▼ -39.1% |
| 2022 | 0.22x | NT$296.56 Million | NT$1.33 Billion | ▼ -30.9% |
| 2021 | 0.32x | NT$280.28 Million | NT$869.26 Million | ▼ -58.6% |
| 2020 | 0.78x | NT$971.53 Million | NT$1.25 Billion | ▼ -40.3% |
| 2019 | 1.30x | NT$791.60 Million | NT$606.84 Million | ▲ +57.2% |
| 2018 | 0.83x | NT$480.18 Million | NT$578.85 Million | ▲ +7.8% |
| 2017 | 0.77x | NT$281.65 Million | NT$365.88 Million | ▼ -26.5% |
| 2016 | 1.05x | NT$502.11 Million | NT$479.43 Million | ▲ +9.7% |
| 2015 | 0.95x | NT$663.24 Million | NT$695.02 Million | ▲ +164.6% |
| 2014 | 0.36x | NT$358.77 Million | NT$994.64 Million | ▲ +48.9% |
| 2013 | 0.24x | NT$238.57 Million | NT$984.62 Million | ▼ -79.8% |
| 2012 | 1.20x | NT$385.57 Million | NT$321.12 Million | ▲ +85.4% |
| 2011 | 0.65x | NT$249.55 Million | NT$385.26 Million | ▲ +10.5% |
| 2010 | 0.59x | NT$218.96 Million | NT$373.37 Million | ▼ -60.3% |
| 2009 | 1.48x | NT$316.96 Million | NT$214.32 Million | ▲ +14.6% |
| 2008 | 1.29x | NT$245.29 Million | NT$190.16 Million | ▲ +36.1% |
| 2007 | 0.95x | NT$167.53 Million | NT$176.74 Million | ▼ -31.6% |
| 2006 | 1.39x | NT$131.62 Million | NT$94.94 Million | ▲ +133.5% |
| 2004 | 0.59x | NT$76.61 Million | NT$129.03 Million | ▼ -70.4% |
| 2003 | 2.01x | NT$206.86 Million | NT$102.99 Million | ▲ +383.3% |
| 2002 | 0.42x | NT$107.12 Million | NT$257.76 Million | — |